An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
Quality of life has become increasingly more important for men diagnosed with prostate cancer. In light of this and the recognized risks of androgen deprivation therapy (ADT), the guidelines and use of ADT have changed significantly over the last few years. This paper reviews the current recommendat...
Saved in:
Main Authors: | Kristene Myklak, Shandra Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2011/419174 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
by: Lior Z. Braunstein, et al.
Published: (2014-01-01) -
Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study
by: Jae Heon Kim, et al.
Published: (2025-01-01) -
Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
by: Katherine Neubecker, et al.
Published: (2017-01-01) -
Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
by: Rahul Aggarwal, et al.
Published: (2022-01-01) -
Androgen deprivation therapy use and the risk of heart failure in patients with prostate cancer: a systematic review and meta-analysis
by: Amir Alinejad Khorram, et al.
Published: (2024-12-01)